13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 6 managers

Reported value

$60.6M

Holders

6

+2 new · −2 exited

Holders’ est. mark

−$18.5M

Price effect on 3 books still in the name

Largest holder

$33.6M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC1.7M$33.6M−$25.1MAdded$4.59M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main12.8M$13.7M$1.73MAdded$1.73M
DANSKE BANK A/S52.3K$12.7M$4.89MAdded$2.32M
Swiss Life Asset Management Ltd1.95K$473.5KNew
Prestige Wealth Management Group LLC272$66.1KHeld

Who left

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.